Nasdaq stocks posting largest percentage increases
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
AGEN: 7.12 (+0.75), AMZN: 445.10 (+55.11), ACTG: 11.10 (+1.08), AFMD: 11.72 (+3.47), CNIT: 5.21 (+0.55), UCTT: 6.26 (+0.60)
Affimed N.V. (AFMD) Shows Strength: Stock Moves Up 15.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 7:51AM CDT
Affimed N.V. (AFMD) was a big mover last session, as its shares rose over 15% on the day.
FLML: 15.88 (+0.02), AFMD: 11.72 (+3.47)
Can the Uptrend Continue for Affimed (AFMD)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 6:37AM CDT
Can the Uptrend Continue for Affimed (AFMD)?
AFMD: 11.72 (+3.47)
Why Affimed (AFMD) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 02, 7:55AM CDT
Affimed's stock not only has a decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well, suggesting that it could be a solid choice for investors.
AFMD: 11.72 (+3.47)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 11:45AM CDT
TANH: 12.29 (+0.54), CCSC: 5.42 (-0.15), STMP: 66.23 (-0.77), HGSH: 3.28 (+0.05), FSNN: 4.24 (-0.18), ATRA: 59.89 (-4.13), KRFT: 87.57 (-0.81), LPTN: 2.23 (-0.01), IIJI: 8.39 (-0.15), KFX: 11.02 (-0.01), ESPR: 104.60 (-4.29), FCSC: 3.87 (+0.12), ORMP: 7.45 (+0.08), AFMD: 11.72 (+3.47), SEED: 1.77 (+0.16), CALA: 13.41 (-0.35), LIME: 2.83 (-0.06), VBLT: 4.23 (+0.07), APOL: 17.51 (-0.40), REPH: 11.88 (+1.04)
Affirmed net loss improves in FY14
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 8:51AM CDT
AFMD: 11.72 (+3.47)
Affimed reports Q4 results
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 6:53AM CDT
AFMD: 11.72 (+3.47)
Affimed Announces Financial Results for Fourth Quarter and Year End 2014
GlobeNewswire - Wed Mar 25, 6:41AM CDT
Affimed N.V. (Nasdaq: AFMD), a clinical-stage biopharmaceutical company developing highly targeted cancer immunotherapies, today reported financial results for the fourth quarter and year ended December 31, 2014.
AFMD: 11.72 (+3.47)
Affimed Completes TandAb Development Candidate Activities Meeting Amphivena's and Janssen's Criteria and Achieves Milestone Ahead of Schedule
GlobeNewswire - Tue Mar 24, 5:09AM CDT
Affimed N.V. (Nasdaq:AFMD), a clinical-stage biopharmaceutical company developing targeted cancer immunotherapies today announced the achievement of the second milestone in its development partnership with Amphivena Therapeutics, Inc. (Amphivena). The milestone represents the development candidate selection against an undisclosed target for the treatment of a certain hematologic malignancy. Affimed, which has a two-fold relationship with Amphivena as both investor and licensor, is due to receive a milestone payment of EUR7.5 million from Amphivena which will be paid in three installments. In addition, in its role as Amphivena shareholder, Affimed will invest its third and last tranche of EUR0.32 million ($0.36 million).
AFMD: 11.72 (+3.47)
Affimed Announces Fourth Quarter and Year End 2014 Financial Results Conference Call
GlobeNewswire - Wed Mar 18, 5:03AM CDT
Affimed N.V. (Nasdaq: AFMD) today announced that on March 25, 2015, the Company will release its financial results for the fourth quarter and year ended December 31, 2014. The Company's management will host a conference call to discuss the Company's financial results and recent corporate developments on Wednesday, March 25, 2015 at 8:30 a.m. EST. The call can be accessed by dialing one of the numbers listed below five minutes prior to the start of the call and providing the confirmation code 1539911.
AFMD: 11.72 (+3.47)
Nasdaq stocks posting largest volume increases
AP - Tue Mar 17, 5:16PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
USAP: 23.92 (+0.38), PNTR: 8.39 (-0.05), MVIS: 3.68 (+0.12), BDE: 9.05 (-0.20), ARTX: 2.85 (-0.07), AFMD: 11.72 (+3.47), WAYN: 13.63 (+0.35), CIZN: 18.97 (+0.18), PCBK: 12.98 (+0.05), HSIC: 142.54 (+0.70)
Affimed N.V. (AFMD) Jumps: Stock Adds 22.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 7:51AM CDT
Affimed N.V. (AFMD) was a big mover last session, as the company saw its shares rise roughly 23% on the day.
LCI: 67.40 (unch), AFMD: 11.72 (+3.47)